Table 2.
Comparison of PASI, VAS, and DLQI scores in placebo and treatment groups at the baseline, weeks 4, 8, and 12.
| Variables | Treatment | SEM | Placebo | SEM | p value |
|---|---|---|---|---|---|
| PASI baseline | 7.22 | 0.61 | 6.47 | 0.42 | 0.31 |
| VAS baseline | 57.64 | 4.64 | 50.29 | 5.31 | 0.30 |
| DLQ baseline | 11.88 | 0.90 | 9.81 | 1.09 | 0.15 |
| PASI week 4 | 6.7 | .60 | 6.44 | 0.41 | 0.72 |
| VAS week 4 | 50.44 | 4.51 | 49.51 | 5.18 | 0.89 |
| DLQI week 4 | 10.76 | 0.83 | 9.70 | 1.01 | 0.42 |
| PASI week 8 | 5.67 | 0.49 | 6.33 | 0.39 | 0.29 |
| VAS week 8 | 41.80 | 4.43 | 48.51 | 4.94 | 0.32 |
| DLQI week 8 | 8.96 | 0.73 | 9.40 | 0.86 | 0.69 |
| PASI week 12 | 4.08 | 0.28 | 6.19 | 0.39 | <0.001 |
| VAS week 12 | 32.24 | 4.29 | 48.11 | 4.88 | 0.019 |
| DLQI week 12 | 6.56 | 0.63 | 8.92 | 0.71 | 0.017 |